nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1B—retina—multiple sclerosis	0.0092	0.301	CbGeAlD
Agomelatine—MTNR1A—nervous system—multiple sclerosis	0.00395	0.129	CbGeAlD
Agomelatine—MTNR1A—central nervous system—multiple sclerosis	0.0038	0.125	CbGeAlD
Agomelatine—MTNR1A—brain—multiple sclerosis	0.00302	0.0988	CbGeAlD
Agomelatine—Eye disorder—Cladribine—multiple sclerosis	0.00296	0.00624	CcSEcCtD
Agomelatine—Infestation NOS—Azathioprine—multiple sclerosis	0.00286	0.00605	CcSEcCtD
Agomelatine—Infestation—Azathioprine—multiple sclerosis	0.00286	0.00605	CcSEcCtD
Agomelatine—Asthenia—Fingolimod—multiple sclerosis	0.00284	0.006	CcSEcCtD
Agomelatine—Pruritus—Fingolimod—multiple sclerosis	0.0028	0.00592	CcSEcCtD
Agomelatine—Mental disorder—Cladribine—multiple sclerosis	0.00277	0.00585	CcSEcCtD
Agomelatine—Diarrhoea—Fingolimod—multiple sclerosis	0.00271	0.00572	CcSEcCtD
Agomelatine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00271	0.00572	CcSEcCtD
Agomelatine—Back pain—Cladribine—multiple sclerosis	0.00266	0.00562	CcSEcCtD
Agomelatine—Dizziness—Fingolimod—multiple sclerosis	0.00262	0.00553	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.0026	0.00549	CcSEcCtD
Agomelatine—Headache—Fingolimod—multiple sclerosis	0.00248	0.00524	CcSEcCtD
Agomelatine—Weight increased—Mitoxantrone—multiple sclerosis	0.00236	0.00499	CcSEcCtD
Agomelatine—Weight decreased—Mitoxantrone—multiple sclerosis	0.00235	0.00496	CcSEcCtD
Agomelatine—Anxiety—Cladribine—multiple sclerosis	0.00234	0.00493	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00233	0.00491	CcSEcCtD
Agomelatine—Jaundice—Mitoxantrone—multiple sclerosis	0.00226	0.00476	CcSEcCtD
Agomelatine—Infection—Cladribine—multiple sclerosis	0.00223	0.00471	CcSEcCtD
Agomelatine—Nervous system disorder—Cladribine—multiple sclerosis	0.0022	0.00465	CcSEcCtD
Agomelatine—Skin disorder—Cladribine—multiple sclerosis	0.00218	0.00461	CcSEcCtD
Agomelatine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00217	0.00458	CcSEcCtD
Agomelatine—Irritability—Methylprednisolone—multiple sclerosis	0.00216	0.00456	CcSEcCtD
Agomelatine—Hepatitis—Mitoxantrone—multiple sclerosis	0.00208	0.00439	CcSEcCtD
Agomelatine—Insomnia—Cladribine—multiple sclerosis	0.00203	0.00429	CcSEcCtD
Agomelatine—Migraine—Betamethasone—multiple sclerosis	0.00202	0.00427	CcSEcCtD
Agomelatine—Migraine—Dexamethasone—multiple sclerosis	0.00202	0.00427	CcSEcCtD
Agomelatine—Paraesthesia—Cladribine—multiple sclerosis	0.00202	0.00426	CcSEcCtD
Agomelatine—Somnolence—Cladribine—multiple sclerosis	0.002	0.00422	CcSEcCtD
Agomelatine—Irritability—Betamethasone—multiple sclerosis	0.00196	0.00414	CcSEcCtD
Agomelatine—Irritability—Dexamethasone—multiple sclerosis	0.00196	0.00414	CcSEcCtD
Agomelatine—Influenza—Triamcinolone—multiple sclerosis	0.00196	0.00414	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00194	0.00409	CcSEcCtD
Agomelatine—Weight increased—Prednisolone—multiple sclerosis	0.00194	0.00409	CcSEcCtD
Agomelatine—Fatigue—Cladribine—multiple sclerosis	0.00194	0.00409	CcSEcCtD
Agomelatine—Constipation—Cladribine—multiple sclerosis	0.00192	0.00406	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00189	0.00399	CcSEcCtD
Agomelatine—HTR2C—brainstem—multiple sclerosis	0.00185	0.0604	CbGeAlD
Agomelatine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00184	0.00388	CcSEcCtD
Agomelatine—Infection—Azathioprine—multiple sclerosis	0.00181	0.00383	CcSEcCtD
Agomelatine—Urticaria—Cladribine—multiple sclerosis	0.00178	0.00377	CcSEcCtD
Agomelatine—Weight increased—Triamcinolone—multiple sclerosis	0.00178	0.00376	CcSEcCtD
Agomelatine—Weight increased—Methylprednisolone—multiple sclerosis	0.00178	0.00375	CcSEcCtD
Agomelatine—Abdominal pain—Cladribine—multiple sclerosis	0.00178	0.00375	CcSEcCtD
Agomelatine—Skin disorder—Azathioprine—multiple sclerosis	0.00177	0.00375	CcSEcCtD
Agomelatine—Back pain—Mitoxantrone—multiple sclerosis	0.00175	0.00369	CcSEcCtD
Agomelatine—Infestation—Methylprednisolone—multiple sclerosis	0.00174	0.00368	CcSEcCtD
Agomelatine—Infestation NOS—Methylprednisolone—multiple sclerosis	0.00174	0.00368	CcSEcCtD
Agomelatine—Face oedema—Prednisone—multiple sclerosis	0.00173	0.00365	CcSEcCtD
Agomelatine—Irritability—Prednisone—multiple sclerosis	0.00171	0.00361	CcSEcCtD
Agomelatine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00171	0.0036	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—multiple sclerosis	0.00167	0.00352	CcSEcCtD
Agomelatine—Weight increased—Betamethasone—multiple sclerosis	0.00162	0.00341	CcSEcCtD
Agomelatine—Weight increased—Dexamethasone—multiple sclerosis	0.00162	0.00341	CcSEcCtD
Agomelatine—Asthenia—Cladribine—multiple sclerosis	0.00161	0.0034	CcSEcCtD
Agomelatine—Weight decreased—Betamethasone—multiple sclerosis	0.00161	0.00339	CcSEcCtD
Agomelatine—Weight decreased—Dexamethasone—multiple sclerosis	0.00161	0.00339	CcSEcCtD
Agomelatine—Pruritus—Cladribine—multiple sclerosis	0.00159	0.00335	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00158	0.00333	CcSEcCtD
Agomelatine—Hallucination—Methylprednisolone—multiple sclerosis	0.00156	0.00329	CcSEcCtD
Agomelatine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00154	0.00325	CcSEcCtD
Agomelatine—Diarrhoea—Cladribine—multiple sclerosis	0.00154	0.00324	CcSEcCtD
Agomelatine—Anxiety—Mitoxantrone—multiple sclerosis	0.00154	0.00324	CcSEcCtD
Agomelatine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00149	0.00315	CcSEcCtD
Agomelatine—Dizziness—Cladribine—multiple sclerosis	0.00149	0.00314	CcSEcCtD
Agomelatine—Infection—Mitoxantrone—multiple sclerosis	0.00147	0.0031	CcSEcCtD
Agomelatine—Eye disorder—Methylprednisolone—multiple sclerosis	0.00146	0.00309	CcSEcCtD
Agomelatine—Abdominal pain—Azathioprine—multiple sclerosis	0.00144	0.00305	CcSEcCtD
Agomelatine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00143	0.00303	CcSEcCtD
Agomelatine—Irritability—Methotrexate—multiple sclerosis	0.00143	0.00302	CcSEcCtD
Agomelatine—Vomiting—Cladribine—multiple sclerosis	0.00143	0.00301	CcSEcCtD
Agomelatine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00143	0.00301	CcSEcCtD
Agomelatine—Hallucination—Betamethasone—multiple sclerosis	0.00142	0.00299	CcSEcCtD
Agomelatine—Hallucination—Dexamethasone—multiple sclerosis	0.00142	0.00299	CcSEcCtD
Agomelatine—Weight increased—Prednisone—multiple sclerosis	0.00141	0.00297	CcSEcCtD
Agomelatine—Headache—Cladribine—multiple sclerosis	0.00141	0.00297	CcSEcCtD
Agomelatine—Weight decreased—Prednisone—multiple sclerosis	0.0014	0.00296	CcSEcCtD
Agomelatine—Vision blurred—Prednisolone—multiple sclerosis	0.0014	0.00295	CcSEcCtD
Agomelatine—Depression—Prednisone—multiple sclerosis	0.00138	0.00291	CcSEcCtD
Agomelatine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00137	0.00289	CcSEcCtD
Agomelatine—Angioedema—Prednisolone—multiple sclerosis	0.00136	0.00286	CcSEcCtD
Agomelatine—Nausea—Cladribine—multiple sclerosis	0.00133	0.00282	CcSEcCtD
Agomelatine—Vertigo—Prednisolone—multiple sclerosis	0.00133	0.00282	CcSEcCtD
Agomelatine—Eye disorder—Betamethasone—multiple sclerosis	0.00133	0.00281	CcSEcCtD
Agomelatine—Eye disorder—Dexamethasone—multiple sclerosis	0.00133	0.00281	CcSEcCtD
Agomelatine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00133	0.0028	CcSEcCtD
Agomelatine—Back pain—Triamcinolone—multiple sclerosis	0.00132	0.00279	CcSEcCtD
Agomelatine—Somnolence—Mitoxantrone—multiple sclerosis	0.00131	0.00277	CcSEcCtD
Agomelatine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.0013	0.00274	CcSEcCtD
Agomelatine—HTR2C—medulla oblongata—multiple sclerosis	0.00129	0.0421	CbGeAlD
Agomelatine—Fatigue—Mitoxantrone—multiple sclerosis	0.00127	0.00269	CcSEcCtD
Agomelatine—Constipation—Mitoxantrone—multiple sclerosis	0.00126	0.00267	CcSEcCtD
Agomelatine—Diarrhoea—Azathioprine—multiple sclerosis	0.00125	0.00264	CcSEcCtD
Agomelatine—Angioedema—Triamcinolone—multiple sclerosis	0.00125	0.00263	CcSEcCtD
Agomelatine—Angioedema—Methylprednisolone—multiple sclerosis	0.00124	0.00263	CcSEcCtD
Agomelatine—Hallucination—Prednisone—multiple sclerosis	0.00123	0.0026	CcSEcCtD
Agomelatine—Vertigo—Triamcinolone—multiple sclerosis	0.00123	0.00259	CcSEcCtD
Agomelatine—Vertigo—Methylprednisolone—multiple sclerosis	0.00122	0.00258	CcSEcCtD
Agomelatine—Connective tissue disorder—Prednisone—multiple sclerosis	0.00122	0.00257	CcSEcCtD
Agomelatine—Dizziness—Azathioprine—multiple sclerosis	0.00121	0.00255	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00121	0.00255	CcSEcCtD
Agomelatine—HTR2C—midbrain—multiple sclerosis	0.00118	0.0385	CbGeAlD
Agomelatine—Urticaria—Mitoxantrone—multiple sclerosis	0.00117	0.00248	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00117	0.00247	CcSEcCtD
Agomelatine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00117	0.00246	CcSEcCtD
Agomelatine—Vomiting—Azathioprine—multiple sclerosis	0.00116	0.00245	CcSEcCtD
Agomelatine—Eye disorder—Prednisone—multiple sclerosis	0.00116	0.00244	CcSEcCtD
Agomelatine—Anxiety—Methylprednisolone—multiple sclerosis	0.00116	0.00244	CcSEcCtD
Agomelatine—Infestation—Methotrexate—multiple sclerosis	0.00115	0.00243	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—multiple sclerosis	0.00115	0.00243	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00115	0.00243	CcSEcCtD
Agomelatine—Depression—Methotrexate—multiple sclerosis	0.00115	0.00243	CcSEcCtD
Agomelatine—HTR2C—spinal cord—multiple sclerosis	0.00115	0.0376	CbGeAlD
Agomelatine—Headache—Azathioprine—multiple sclerosis	0.00114	0.00242	CcSEcCtD
Agomelatine—Dry mouth—Triamcinolone—multiple sclerosis	0.00114	0.0024	CcSEcCtD
Agomelatine—Angioedema—Dexamethasone—multiple sclerosis	0.00113	0.00239	CcSEcCtD
Agomelatine—Angioedema—Betamethasone—multiple sclerosis	0.00113	0.00239	CcSEcCtD
Agomelatine—Vertigo—Dexamethasone—multiple sclerosis	0.00111	0.00235	CcSEcCtD
Agomelatine—Vertigo—Betamethasone—multiple sclerosis	0.00111	0.00235	CcSEcCtD
Agomelatine—Infection—Triamcinolone—multiple sclerosis	0.00111	0.00234	CcSEcCtD
Agomelatine—Infection—Methylprednisolone—multiple sclerosis	0.0011	0.00233	CcSEcCtD
Agomelatine—Insomnia—Prednisolone—multiple sclerosis	0.0011	0.00231	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00109	0.0023	CcSEcCtD
Agomelatine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00109	0.0023	CcSEcCtD
Agomelatine—Paraesthesia—Prednisolone—multiple sclerosis	0.00109	0.0023	CcSEcCtD
Agomelatine—Mental disorder—Prednisone—multiple sclerosis	0.00109	0.00229	CcSEcCtD
Agomelatine—Nausea—Azathioprine—multiple sclerosis	0.00109	0.00229	CcSEcCtD
Agomelatine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00108	0.00228	CcSEcCtD
Agomelatine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00108	0.00227	CcSEcCtD
Agomelatine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00107	0.00227	CcSEcCtD
Agomelatine—Asthenia—Mitoxantrone—multiple sclerosis	0.00106	0.00224	CcSEcCtD
Agomelatine—Anxiety—Betamethasone—multiple sclerosis	0.00105	0.00222	CcSEcCtD
Agomelatine—Anxiety—Dexamethasone—multiple sclerosis	0.00105	0.00222	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—multiple sclerosis	0.00104	0.00219	CcSEcCtD
Agomelatine—Vision blurred—Prednisone—multiple sclerosis	0.00102	0.00215	CcSEcCtD
Agomelatine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00101	0.00213	CcSEcCtD
Agomelatine—Insomnia—Triamcinolone—multiple sclerosis	0.00101	0.00213	CcSEcCtD
Agomelatine—Insomnia—Methylprednisolone—multiple sclerosis	0.00101	0.00212	CcSEcCtD
Agomelatine—Infection—Betamethasone—multiple sclerosis	0.001	0.00212	CcSEcCtD
Agomelatine—Infection—Dexamethasone—multiple sclerosis	0.001	0.00212	CcSEcCtD
Agomelatine—Paraesthesia—Triamcinolone—multiple sclerosis	0.001	0.00211	CcSEcCtD
Agomelatine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000998	0.00211	CcSEcCtD
Agomelatine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000991	0.00209	CcSEcCtD
Agomelatine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000991	0.00209	CcSEcCtD
Agomelatine—Agitation—Prednisone—multiple sclerosis	0.000991	0.00209	CcSEcCtD
Agomelatine—Angioedema—Prednisone—multiple sclerosis	0.000986	0.00208	CcSEcCtD
Agomelatine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000981	0.00207	CcSEcCtD
Agomelatine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000979	0.00207	CcSEcCtD
Agomelatine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000977	0.00206	CcSEcCtD
Agomelatine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000977	0.00206	CcSEcCtD
Agomelatine—Vertigo—Prednisone—multiple sclerosis	0.000969	0.00205	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—multiple sclerosis	0.000968	0.00204	CcSEcCtD
Agomelatine—HTR2C—nervous system—multiple sclerosis	0.000967	0.0317	CbGeAlD
Agomelatine—Tinnitus—Methotrexate—multiple sclerosis	0.000966	0.00204	CcSEcCtD
Agomelatine—Urticaria—Prednisolone—multiple sclerosis	0.000962	0.00203	CcSEcCtD
Agomelatine—Fatigue—Triamcinolone—multiple sclerosis	0.000961	0.00203	CcSEcCtD
Agomelatine—Fatigue—Methylprednisolone—multiple sclerosis	0.000958	0.00202	CcSEcCtD
Agomelatine—Vomiting—Mitoxantrone—multiple sclerosis	0.000939	0.00198	CcSEcCtD
Agomelatine—HTR2C—central nervous system—multiple sclerosis	0.000931	0.0305	CbGeAlD
Agomelatine—Headache—Mitoxantrone—multiple sclerosis	0.000925	0.00195	CcSEcCtD
Agomelatine—Anxiety—Prednisone—multiple sclerosis	0.000915	0.00193	CcSEcCtD
Agomelatine—Insomnia—Dexamethasone—multiple sclerosis	0.000914	0.00193	CcSEcCtD
Agomelatine—Insomnia—Betamethasone—multiple sclerosis	0.000914	0.00193	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000912	0.00193	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000909	0.00192	CcSEcCtD
Agomelatine—HTR2B—nervous system—multiple sclerosis	0.000909	0.0297	CbGeAlD
Agomelatine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000908	0.00192	CcSEcCtD
Agomelatine—Paraesthesia—Betamethasone—multiple sclerosis	0.000908	0.00192	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—multiple sclerosis	0.000907	0.00191	CcSEcCtD
Agomelatine—Dyspepsia—Betamethasone—multiple sclerosis	0.00089	0.00188	CcSEcCtD
Agomelatine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00089	0.00188	CcSEcCtD
Agomelatine—Urticaria—Triamcinolone—multiple sclerosis	0.000885	0.00187	CcSEcCtD
Agomelatine—Urticaria—Methylprednisolone—multiple sclerosis	0.000883	0.00186	CcSEcCtD
Agomelatine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000879	0.00185	CcSEcCtD
Agomelatine—Nausea—Mitoxantrone—multiple sclerosis	0.000877	0.00185	CcSEcCtD
Agomelatine—HTR2B—central nervous system—multiple sclerosis	0.000875	0.0286	CbGeAlD
Agomelatine—Infection—Prednisone—multiple sclerosis	0.000875	0.00185	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000873	0.00184	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000873	0.00184	CcSEcCtD
Agomelatine—Back pain—Methotrexate—multiple sclerosis	0.000872	0.00184	CcSEcCtD
Agomelatine—Fatigue—Betamethasone—multiple sclerosis	0.000872	0.00184	CcSEcCtD
Agomelatine—Fatigue—Dexamethasone—multiple sclerosis	0.000872	0.00184	CcSEcCtD
Agomelatine—Nervous system disorder—Prednisone—multiple sclerosis	0.000863	0.00182	CcSEcCtD
Agomelatine—Skin disorder—Prednisone—multiple sclerosis	0.000855	0.0018	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000851	0.0018	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—multiple sclerosis	0.00085	0.00179	CcSEcCtD
Agomelatine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000827	0.00174	CcSEcCtD
Agomelatine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000827	0.00174	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—multiple sclerosis	0.00081	0.00171	CcSEcCtD
Agomelatine—Urticaria—Dexamethasone—multiple sclerosis	0.000803	0.0017	CcSEcCtD
Agomelatine—Urticaria—Betamethasone—multiple sclerosis	0.000803	0.0017	CcSEcCtD
Agomelatine—Dizziness—Prednisolone—multiple sclerosis	0.000801	0.00169	CcSEcCtD
Agomelatine—Asthenia—Triamcinolone—multiple sclerosis	0.000799	0.00169	CcSEcCtD
Agomelatine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000799	0.00169	CcSEcCtD
Agomelatine—Abdominal pain—Betamethasone—multiple sclerosis	0.000799	0.00169	CcSEcCtD
Agomelatine—Asthenia—Methylprednisolone—multiple sclerosis	0.000798	0.00168	CcSEcCtD
Agomelatine—Insomnia—Prednisone—multiple sclerosis	0.000796	0.00168	CcSEcCtD
Agomelatine—Paraesthesia—Prednisone—multiple sclerosis	0.000791	0.00167	CcSEcCtD
Agomelatine—Pruritus—Triamcinolone—multiple sclerosis	0.000788	0.00166	CcSEcCtD
Agomelatine—Pruritus—Methylprednisolone—multiple sclerosis	0.000786	0.00166	CcSEcCtD
Agomelatine—Dyspepsia—Prednisone—multiple sclerosis	0.000775	0.00164	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000762	0.00161	CcSEcCtD
Agomelatine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000761	0.00161	CcSEcCtD
Agomelatine—Fatigue—Prednisone—multiple sclerosis	0.000759	0.0016	CcSEcCtD
Agomelatine—Headache—Prednisolone—multiple sclerosis	0.000759	0.0016	CcSEcCtD
Agomelatine—Constipation—Prednisone—multiple sclerosis	0.000753	0.00159	CcSEcCtD
Agomelatine—HTR2C—brain—multiple sclerosis	0.000739	0.0242	CbGeAlD
Agomelatine—Dizziness—Triamcinolone—multiple sclerosis	0.000737	0.00156	CcSEcCtD
Agomelatine—Dizziness—Methylprednisolone—multiple sclerosis	0.000735	0.00155	CcSEcCtD
Agomelatine—Infection—Methotrexate—multiple sclerosis	0.000731	0.00154	CcSEcCtD
Agomelatine—Asthenia—Dexamethasone—multiple sclerosis	0.000725	0.00153	CcSEcCtD
Agomelatine—Asthenia—Betamethasone—multiple sclerosis	0.000725	0.00153	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000722	0.00152	CcSEcCtD
Agomelatine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00072	0.00152	CcSEcCtD
Agomelatine—Nausea—Prednisolone—multiple sclerosis	0.00072	0.00152	CcSEcCtD
Agomelatine—Pruritus—Dexamethasone—multiple sclerosis	0.000715	0.00151	CcSEcCtD
Agomelatine—Pruritus—Betamethasone—multiple sclerosis	0.000715	0.00151	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—multiple sclerosis	0.000715	0.00151	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000711	0.0015	CcSEcCtD
Agomelatine—Vomiting—Triamcinolone—multiple sclerosis	0.000708	0.0015	CcSEcCtD
Agomelatine—Vomiting—Methylprednisolone—multiple sclerosis	0.000707	0.00149	CcSEcCtD
Agomelatine—Urticaria—Prednisone—multiple sclerosis	0.000699	0.00148	CcSEcCtD
Agomelatine—Headache—Triamcinolone—multiple sclerosis	0.000698	0.00147	CcSEcCtD
Agomelatine—Headache—Methylprednisolone—multiple sclerosis	0.000696	0.00147	CcSEcCtD
Agomelatine—Abdominal pain—Prednisone—multiple sclerosis	0.000696	0.00147	CcSEcCtD
Agomelatine—HTR2B—brain—multiple sclerosis	0.000695	0.0227	CbGeAlD
Agomelatine—Diarrhoea—Betamethasone—multiple sclerosis	0.000692	0.00146	CcSEcCtD
Agomelatine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000692	0.00146	CcSEcCtD
Agomelatine—Dizziness—Betamethasone—multiple sclerosis	0.000668	0.00141	CcSEcCtD
Agomelatine—Dizziness—Dexamethasone—multiple sclerosis	0.000668	0.00141	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—multiple sclerosis	0.000665	0.0014	CcSEcCtD
Agomelatine—Nausea—Triamcinolone—multiple sclerosis	0.000662	0.0014	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—multiple sclerosis	0.000661	0.00139	CcSEcCtD
Agomelatine—Nausea—Methylprednisolone—multiple sclerosis	0.00066	0.00139	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—multiple sclerosis	0.000654	0.00138	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—multiple sclerosis	0.000648	0.00137	CcSEcCtD
Agomelatine—Vomiting—Dexamethasone—multiple sclerosis	0.000643	0.00136	CcSEcCtD
Agomelatine—Vomiting—Betamethasone—multiple sclerosis	0.000643	0.00136	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000635	0.00134	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—multiple sclerosis	0.000634	0.00134	CcSEcCtD
Agomelatine—Headache—Betamethasone—multiple sclerosis	0.000633	0.00134	CcSEcCtD
Agomelatine—Headache—Dexamethasone—multiple sclerosis	0.000633	0.00134	CcSEcCtD
Agomelatine—Asthenia—Prednisone—multiple sclerosis	0.000632	0.00133	CcSEcCtD
Agomelatine—Pruritus—Prednisone—multiple sclerosis	0.000623	0.00131	CcSEcCtD
Agomelatine—Diarrhoea—Prednisone—multiple sclerosis	0.000602	0.00127	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000602	0.00127	CcSEcCtD
Agomelatine—Nausea—Betamethasone—multiple sclerosis	0.0006	0.00127	CcSEcCtD
Agomelatine—Nausea—Dexamethasone—multiple sclerosis	0.0006	0.00127	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—multiple sclerosis	0.000584	0.00123	CcSEcCtD
Agomelatine—Dizziness—Prednisone—multiple sclerosis	0.000582	0.00123	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—multiple sclerosis	0.000582	0.00123	CcSEcCtD
Agomelatine—Vomiting—Prednisone—multiple sclerosis	0.00056	0.00118	CcSEcCtD
Agomelatine—Headache—Prednisone—multiple sclerosis	0.000552	0.00116	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—multiple sclerosis	0.000528	0.00111	CcSEcCtD
Agomelatine—Nausea—Prednisone—multiple sclerosis	0.000523	0.0011	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—multiple sclerosis	0.000521	0.0011	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—multiple sclerosis	0.000503	0.00106	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—multiple sclerosis	0.000487	0.00103	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—multiple sclerosis	0.000468	0.000987	CcSEcCtD
Agomelatine—Headache—Methotrexate—multiple sclerosis	0.000461	0.000973	CcSEcCtD
Agomelatine—Nausea—Methotrexate—multiple sclerosis	0.000437	0.000922	CcSEcCtD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00036	0.000726	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—S1PR1—multiple sclerosis	0.00036	0.000726	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GPR65—multiple sclerosis	0.000359	0.000725	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CNR1—multiple sclerosis	0.000358	0.000722	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000358	0.000722	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTGER4—multiple sclerosis	0.000354	0.000715	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000349	0.000705	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LINGO1—multiple sclerosis	0.000348	0.000701	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000343	0.000692	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCR3—multiple sclerosis	0.000342	0.000691	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000342	0.000689	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—RGS1—multiple sclerosis	0.000337	0.000679	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR2—multiple sclerosis	0.000333	0.000672	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00033	0.000667	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—POMC—multiple sclerosis	0.00033	0.000667	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—POMC—multiple sclerosis	0.00033	0.000667	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000329	0.000664	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000329	0.000664	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR1—multiple sclerosis	0.000329	0.000663	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000329	0.000663	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000328	0.000661	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000323	0.000652	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCL2—multiple sclerosis	0.000323	0.000652	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000322	0.00065	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL10—multiple sclerosis	0.000322	0.00065	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GPR65—multiple sclerosis	0.000319	0.000644	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000313	0.000631	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00031	0.000625	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00031	0.000625	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CNR1—multiple sclerosis	0.000307	0.00062	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RGS1—multiple sclerosis	0.000306	0.000617	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TAGAP—multiple sclerosis	0.000301	0.000608	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL5—multiple sclerosis	0.000295	0.000596	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000294	0.000592	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TYK2—multiple sclerosis	0.000294	0.000592	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000292	0.000589	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR1—multiple sclerosis	0.000292	0.000589	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000292	0.000589	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GPR65—multiple sclerosis	0.00029	0.000585	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000282	0.000568	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CD86—multiple sclerosis	0.000282	0.000568	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CD86—multiple sclerosis	0.000282	0.000568	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LINGO1—multiple sclerosis	0.00028	0.000566	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL5—multiple sclerosis	0.000277	0.000559	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL5—multiple sclerosis	0.000277	0.000559	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL10—multiple sclerosis	0.000277	0.000558	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000273	0.000551	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000269	0.000543	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—IL2—multiple sclerosis	0.000269	0.000543	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000267	0.000539	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCR5—multiple sclerosis	0.000266	0.000537	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR1—multiple sclerosis	0.000265	0.000535	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL13—multiple sclerosis	0.000265	0.000535	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000265	0.000534	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000265	0.000534	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000264	0.000533	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—S1PR1—multiple sclerosis	0.000263	0.000531	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000257	0.000519	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000257	0.000518	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SPP1—multiple sclerosis	0.000257	0.000518	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SPP1—multiple sclerosis	0.000257	0.000518	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GPC5—multiple sclerosis	0.000256	0.000517	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000252	0.000508	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCR5—multiple sclerosis	0.00025	0.000504	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCR5—multiple sclerosis	0.00025	0.000504	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000248	0.000501	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000246	0.000497	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL2RA—multiple sclerosis	0.000246	0.000497	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL2—multiple sclerosis	0.000244	0.000493	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL2—multiple sclerosis	0.000244	0.000493	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TAGAP—multiple sclerosis	0.000243	0.00049	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.00024	0.000484	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.00024	0.000484	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00024	0.000484	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL5—multiple sclerosis	0.000238	0.000481	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL3—multiple sclerosis	0.000234	0.000473	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000233	0.000471	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APOE—multiple sclerosis	0.000227	0.000458	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APOE—multiple sclerosis	0.000227	0.000458	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTGER4—multiple sclerosis	0.000225	0.000455	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RGS1—multiple sclerosis	0.000224	0.000452	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00022	0.000444	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000218	0.000439	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000215	0.000435	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000215	0.000434	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR5—multiple sclerosis	0.000215	0.000433	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—S1PR1—multiple sclerosis	0.000212	0.000429	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GPR65—multiple sclerosis	0.000212	0.000428	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR2—multiple sclerosis	0.000212	0.000427	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000208	0.000421	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—POMC—multiple sclerosis	0.000208	0.000419	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GPC5—multiple sclerosis	0.000207	0.000417	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CD80—multiple sclerosis	0.000205	0.000414	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CD80—multiple sclerosis	0.000205	0.000414	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL2—multiple sclerosis	0.000203	0.00041	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0002	0.000404	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000196	0.000395	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CNR1—multiple sclerosis	0.000195	0.000394	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—POMC—multiple sclerosis	0.000195	0.000394	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—POMC—multiple sclerosis	0.000195	0.000394	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL13—multiple sclerosis	0.000194	0.000392	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR1—multiple sclerosis	0.000194	0.000392	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000194	0.000391	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000193	0.00039	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL2—multiple sclerosis	0.000191	0.000385	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL2—multiple sclerosis	0.000191	0.000385	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL3—multiple sclerosis	0.000189	0.000381	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR2—multiple sclerosis	0.000188	0.00038	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000187	0.000377	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000187	0.000377	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTGER4—multiple sclerosis	0.000182	0.000367	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000181	0.000366	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RGS1—multiple sclerosis	0.000181	0.000365	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000176	0.000355	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCR3—multiple sclerosis	0.000176	0.000354	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	0.000174	0.00035	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TYK2—multiple sclerosis	0.000173	0.00035	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TYK2—multiple sclerosis	0.000173	0.00035	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	0.000171	0.000346	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	0.000171	0.000345	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000168	0.000339	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	0.000168	0.000338	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SRM—multiple sclerosis	0.000167	0.000338	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000167	0.000337	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	0.000164	0.000331	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00016	0.000323	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	0.000158	0.000318	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	0.000157	0.000316	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	0.000157	0.000316	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000156	0.000315	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	0.000155	0.000313	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	0.000152	0.000306	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.00015	0.000303	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000148	0.000299	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL2—multiple sclerosis	0.000144	0.000291	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL2—multiple sclerosis	0.000144	0.000291	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—multiple sclerosis	0.000144	0.00029	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—multiple sclerosis	0.000144	0.00029	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	0.000142	0.000286	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	0.000138	0.000279	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.000138	0.000278	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.000138	0.000278	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—multiple sclerosis	0.000137	0.000276	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—multiple sclerosis	0.000137	0.000276	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000136	0.000275	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000135	0.000272	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	0.000135	0.000272	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000135	0.000271	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000133	0.000269	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PGR—multiple sclerosis	0.000131	0.000265	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000129	0.000261	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000129	0.00026	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CD28—multiple sclerosis	0.000127	0.000257	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPC5—multiple sclerosis	0.000126	0.000255	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	0.000125	0.000252	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	0.000122	0.000247	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—multiple sclerosis	0.000121	0.000245	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—multiple sclerosis	0.000121	0.000245	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	0.000121	0.000245	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00012	0.000241	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	0.000118	0.000238	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	0.000118	0.000238	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	0.000117	0.000237	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	0.000115	0.000233	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000115	0.000232	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—multiple sclerosis	0.000113	0.000228	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—multiple sclerosis	0.000113	0.000228	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—multiple sclerosis	0.000113	0.000227	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—multiple sclerosis	0.000113	0.000227	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	0.000112	0.000225	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK1—multiple sclerosis	0.00011	0.000223	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK1—multiple sclerosis	0.00011	0.000223	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	0.00011	0.000222	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	0.000109	0.000219	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPC5—multiple sclerosis	0.000108	0.000218	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	0.000107	0.000217	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	0.000107	0.000215	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	0.000106	0.000213	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—RRM1—multiple sclerosis	0.000105	0.000211	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	0.000104	0.000211	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	0.000104	0.00021	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	0.000104	0.000209	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	0.000103	0.000207	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	0.000101	0.000204	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	9.48e-05	0.000191	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	9.48e-05	0.000191	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	9.32e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CD86—multiple sclerosis	9.09e-05	0.000183	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	8.95e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.93e-05	0.00018	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	8.68e-05	0.000175	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	8.61e-05	0.000174	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—multiple sclerosis	8.48e-05	0.000171	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—multiple sclerosis	8.48e-05	0.000171	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	8.42e-05	0.00017	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	8.39e-05	0.000169	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	8.29e-05	0.000167	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.11e-05	0.000164	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	8.06e-05	0.000163	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	7.95e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	7.89e-05	0.000159	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	7.65e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	7.34e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	7.33e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	7.22e-05	0.000146	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	7.01e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.97e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.93e-05	0.00014	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	6.69e-05	0.000135	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	6.63e-05	0.000134	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	6.51e-05	0.000131	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	6.41e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	6.36e-05	0.000128	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.35e-05	0.000128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	6.3e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	6.17e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	6.03e-05	0.000122	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCHE—multiple sclerosis	6e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.95e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	5.92e-05	0.000119	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	5.6e-05	0.000113	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.43e-05	0.00011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	5.35e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCHE—multiple sclerosis	5.13e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	5.08e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	4.97e-05	0.0001	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	4.87e-05	9.82e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	4.66e-05	9.4e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	4.64e-05	9.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	4.52e-05	9.11e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	4.41e-05	8.9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	3.92e-05	7.91e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	3.76e-05	7.58e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	3.74e-05	7.54e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	3.64e-05	7.35e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	3.63e-05	7.33e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.61e-05	7.29e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	3.56e-05	7.19e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	3.56e-05	7.18e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	3.16e-05	6.38e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—multiple sclerosis	3.1e-05	6.26e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—multiple sclerosis	3.09e-05	6.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	2.94e-05	5.93e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	2.93e-05	5.91e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	2.88e-05	5.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.83e-05	5.71e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	2.74e-05	5.52e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—multiple sclerosis	2.65e-05	5.35e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—multiple sclerosis	2.42e-05	4.88e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	2.21e-05	4.46e-05	CbGpPWpGaD
